pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,244 catalysts · 4,970 phase readout · 2,346 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 17 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,970
  • 8k filing2,346
  • earnings287
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
  • phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Infectious Disease1

    Date TBD

    50
    ›TERMINATEDphase readoutNCT06704724: A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

    Sponsor: Pfizer. Phase: PHASE1. Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06946680: IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

    Sponsor: University of Florida. Phase: PHASE1. Conditions: High-grade Glioma, Diffuse Intrinsic Pontine Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06573996: The Effect of Intraoral Transcutaneous Electrical Nerve Stimulation in Orthodontics Pain

    Sponsor: University of the Pacific. Phase: NA. Conditions: Orthodontic Appliance, Pain, Transcutaneous Electric Nerve Stimulation, Orthodontic Appliance Complication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06638996: Acute Psychological and Physiological Effects of Cannabigerol

    Sponsor: Washington State University. Phase: NA. Conditions: No Disease or Condition is Being Studied

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06650462: Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1

    Sponsor: Old Dominion University. Phase: NA. Conditions: COVID-19, Trust

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05665062: Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies

    Sponsor: Synthekine. Phase: PHASE1. Conditions: CLL/SLL, NHL, Mantle Cell Lymphoma, Follicular Lymphoma, Large B-cell Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06273046: Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback

    Sponsor: Hospital Universitari Vall d'Hebron Research Institute. Phase: NA. Conditions: Fecal Incontinence, Outlet Dysfunction Constipation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07530146: Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

    Sponsor: Helwan University. Phase: PHASE3. Conditions: The Critically Ill Patient is Requiring Intubation, Septic Shock, Pneumonia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03747627: BPF Genetics of ILD Study

    Sponsor: University of Dundee. Phase: . Conditions: Lung; Disease, Interstitial, With Fibrosis, Alveolitis, Extrinsic Allergic, Bird Fancier's Lung, Idiopathic Interstitial Pneumonias, Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04934527: Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection

    Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Kidney Transplantation, CMV Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07639086: Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy

    Sponsor: Virginia Commonwealth University. Phase: PHASE2. Conditions: Prostate Cancer, Neuroendocrine Prostate Cancer (NEPC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07453342: Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

    Sponsor: Peking Union Medical College Hospital. Phase: . Conditions: Immune-Related Adverse Events

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07356570: Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Post-Acute COVID-19 Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07338370: Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates

    Sponsor: Ain Shams University. Phase: . Conditions: Neonatal Prematurity, Patent Ductus Arteriosus in Preterm Infants, Prostaglandins

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07505641: Breathing and Decision-Making (ProlEx-Context)

    Sponsor: German Institute of Human Nutrition. Phase: NA. Conditions: Breathing Techniques, Stress Management, Decision-Making

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07633769: Virtual Reality-based Rehabilitation for Traumatic Hand and Wrist Injuries

    Sponsor: University of Malaga. Phase: NA. Conditions: Wrist Injury, Hand and Upper Limb Trauma, Hand and Forearm Trauma, Muskuloskeletal Diseases

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03543969: Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: EARLY_PHASE1. Conditions: Melanoma (Skin), Skin Cancer, Skin Melanoma, Skin Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07416383: Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE1. Conditions: Inflamatory Bowel Disease, Crohn Disease (CD), Ulcerative Colitis (UC)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05234983: Adapting and Evaluating a Brief Advice Tobacco Intervention in High-Reach, Low-Resource Settings in India

    Sponsor: Harvard School of Public Health (HSPH). Phase: NA. Conditions: Tobacco Use Cessation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04332341: Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

    Sponsor: Case Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Allogeneic Hematopoietic Cell Transplantation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05153317: Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older

    Sponsor: Vertex Pharmaceuticals Incorporated. Phase: PHASE3. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07122817: Emotional Suppression in Elderly Individuals

    Sponsor: Istinye University. Phase: . Conditions: Elderly Person

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05669989: International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

    Sponsor: Sanofi. Phase: PHASE2. Conditions: Plasma Cell Myeloma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06139874: Thrive Intervention in Schools

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Childhood Mental Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00540774: Optical Sensor for Photodynamic Detection of Oral Pathology

    Sponsor: University of California, Irvine. Phase: NA. Conditions: Mouth Diseases

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05515874: Predicting Stroke Risk in ICAD With Novel MRI

    Sponsor: Northwestern University. Phase: PHASE4. Conditions: Intracranial Atherosclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07572474: Correlation Between Pinch Grip and Handwriting in School-Age Children

    Sponsor: October 6 University. Phase: . Conditions: Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06831318: Community Health Worker-Led Transition Support for Persons Living With Dementia and Caregivers

    Sponsor: University of Texas at Austin. Phase: NA. Conditions: Cognitive Impairment, Dementia, Memory Deficits

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06813118: Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

    Sponsor: HITEC-Institute of Medical Sciences. Phase: PHASE1. Conditions: Polycystic Ovarian Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06832618: A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

    Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07522918: Single-Session Extraoral PBM After Third Molar Extraction

    Sponsor: Konya Necmettin Erbakan Üniversitesi. Phase: NA. Conditions: Impacted Mandibular Third Molar, Edema, Trismus, Postoperative Pain

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07465497: Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

    Sponsor: Instituto Jalisciense de Cancerologia. Phase: NA. Conditions: Chemobrain, Breast Cancer, Inflammatory Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05756413: Birth to Three - Cavity Free

    Sponsor: University of Iowa. Phase: NA. Conditions: Caries,Dental

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06498713: Patient Controlled Administration of Liquid Acetaminophen

    Sponsor: Yale University. Phase: PHASE1. Conditions: Pain, Pain, Postoperative

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06201429: A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR®) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.

    Sponsor: Renovo Concepts, Inc.. Phase: NA. Conditions: Clinical Need for Craniotomy or Craniectomy, Clinical Need for Cranioplasty

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06353529: Postop Pain Management in Pituitary Tumour Patients

    Sponsor: Hamilton Health Sciences Corporation. Phase: PHASE4. Conditions: Pituitary, Pain, Postoperative

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07359729: Deep Breathing and Virtual Reality for Venipuncture Pain

    Sponsor: Universidad Autónoma del Estado de Hidalgo. Phase: NA. Conditions: Pain Management, Anxiety, Virtual Reality, Breathing Exercises, Pain Measurement, Patient Satisfaction

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07422051: Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis

    Sponsor: Spanish National Research Council. Phase: PHASE2. Conditions: Atherosclerosis Cardiovascular Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07450651: Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

    Sponsor: Beijing Friendship Hospital. Phase: . Conditions: Hepatitis B Virus Related Cirrhosis, Portal Hypertension Related to Cirrhosis, Esophagogastric Varices

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04750551: BreEStim for Post-Stroke Motor Recovery

    Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Motor Recovery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00549731: Participant Database for Autism Research Studies

    Sponsor: Massachusetts General Hospital. Phase: . Conditions: Autism Spectrum Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05768802: Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation

    Sponsor: Boninger, Michael, MD. Phase: NA. Conditions: Amputation, Amputation; Traumatic, Hand

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05931302: Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT

    Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: NA. Conditions: Lobular Breast Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06065202: Personalized Nutrition to Improve Recovery in Trauma

    Sponsor: Duke University. Phase: PHASE2. Conditions: Abdominal Trauma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06386653: Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

    Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences. Phase: PHASE1. Conditions: Lung Cancer, Ovarian Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07379437: Haematococcus Pluvialis Astaxanthin for Brain Aging

    Sponsor: Capital Medical University. Phase: NA. Conditions: Brain Aging

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05469737: A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

    Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Myelodysplastic Syndromes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

    Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03986437: A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.

    Sponsor: Institut Claudius Regaud. Phase: . Conditions: Differentiated Thyroid Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04658251: Study of New Mutations in Cone Disorders

    Sponsor: University Hospital, Lille. Phase: . Conditions: Retinal Dystrophy, Cone-Rod, Cone Dystrophy, Cone Rod Dystrophy, Macular Degeneration

    full page →ctgov ↗
    ← prev
    page 88 of 105
    next →